Young M A, Watson R D, Stallard T J, Littler W A
Br J Clin Pharmacol. 1985;20 Suppl 1(Suppl 1):95S-98S. doi: 10.1111/j.1365-2125.1985.tb05149.x.
Seven untreated patients with essential hypertension but without target organ damage were admitted to hospital. Urine was collected the following day from 08.00 to 13.00 h, 13.00 to 18.00 h, and 18.00 to 08.00 h. The protocol was repeated the next day following 30 mg oral nicardipine. Intra-arterial blood pressure (IABP), plasma volume, and plasma renin activity (PRA) also were measured daily. Following the single-dose study, the patients were treated as outpatients and received oral nicardipine 20, 30, or 40 mg four times daily. They were readmitted 2 months later for further study, at which time the protocol was repeated. Urine output between 08.00 and 13.00 h significantly increased after the single- and multiple-dose studies. Following the single-dose study, this diuresis was associated with a natriuresis. Urine output increased over the 24 h following multiple-dose treatment, but this increase was not statistically significant. During the multiple-dose 24 h study, there was an increase in urinary potassium (P less than 0.05). Mean IABP was reduced significantly after the single- and multiple-dose studies (P less than 0.02 and less than 0.05, respectively). During the study, there were no significant changes in plasma volume, weight, or plasma renin activity.
七名未接受治疗的原发性高血压患者被收治入院,他们均无靶器官损害。次日,分别于08:00至13:00、13:00至18:00以及18:00至08:00收集尿液。在口服30毫克尼卡地平后的次日重复该方案。每天还测量动脉内血压(IABP)、血浆容量和血浆肾素活性(PRA)。单剂量研究后,患者作为门诊病人接受治疗,每日口服尼卡地平20、30或40毫克,分四次服用。两个月后他们再次入院进行进一步研究,此时重复该方案。单剂量和多剂量研究后,08:00至13:00的尿量显著增加。单剂量研究后,这种利尿作用与利钠作用相关。多剂量治疗后24小时内尿量增加,但这种增加无统计学意义。在多剂量24小时研究期间,尿钾增加(P<0.05)。单剂量和多剂量研究后,平均动脉内血压均显著降低(分别为P<0.02和P<0.05)。研究期间,血浆容量、体重或血浆肾素活性无显著变化。